As the technology, life sciences, and private equity industries continue to fuel deal activity around the world, Goodwin’s Israel practice continues its momentum as the go-to law firm for Israeli companies, founders, and investors in these sectors. In the past month alone, the practice advised five Israel-based or Israeli-founded technology and life sciences companies in raising over $400 million in funding; represented the lead investors in the financing of two Israeli-founded technology companies in an aggregate amount of $90 million; and counseled the financial advisors on a de-SPAC transaction with an Israel-based target. This activity follows a prolific 2020, during which Goodwin’s Israel practice handled over 20 deals involving Israel-based investors, founders or companies, including mergers and acquisitions, equity financings, and public offerings. Select transactions from the past month include:
- Representation of Augmedics, Inc., an Israel- and Chicago-based augmented reality surgical image guidance pioneer, on its $36 million over-subscribed Series C financing with an international syndicate of Israel-U.S. investors. The Goodwin team included Mayan Katz, Kaitlin Carragher, Roger Cohen, Rebecca Kennedy, and Mark Burnett.
- Representation of Capitolis Inc., an Israel-, New York-, and London-based Capital markets SaaS platform, on its $90 million Series C funding round led by Andreessen Horowitz. The Goodwin team included Larry Chu, Bill Stern, and Bryan Snyder.
- Representation of Vascular Biogenics Ltd. (NASDAQ: VBLT), an Israeli clinical stage biopharmaceutical company, on its $28.3 underwritten public offering. The Goodwin team included Larry Wittenberg, Mayan Katz, Amanda Rae Schwarzenbart, Romina Weiss, and Ettore Santucci.
Goodwin’s Israel practice provides solutions and produces results for companies doing business in Israel, as well as investors interested in investment opportunities in the region, by leveraging the experience of lawyers working across the firm’s practices areas and global office locations.